Current Trends of Combination Therapy in Chronic Hepatitis B Management in China
<p>In the past decade, five oral nucleos(t)ide analogs and two formulations of pegylated interferon alpha have been approved for the treatment of chronic hepatitis B (CHB). Due to low personal income and inadequate health care system, low-to-moderate genetic barrier antiviral drugs are still w...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
Archives of Hepatitis Research - Peertechz Publications,
2015-08-28.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|